Results 101 to 110 of about 3,337,856 (280)

The prognostic and risk-stratified value of neutrophil–lymphocyte count ratio in Chinese patients with community-acquired pneumonia

European Journal of Inflammation, 2017
Community-acquired pneumonia is a common disease associated with high mortality. This retrospective study examined whether the neutrophil–lymphocyte count ratio (NLR), already widely used as an index of inflammation, can be used to predict in-hospital ...
Ting Yang, Chun Wan, Hao Wang, Jiangyue Qin, Lei Chen, Yongchun Shen, Fuqiang Wen   +6 more
doaj   +1 more source

Biventricular Pressure‐Volume Loop Analysis in an LVAD Patient Optimized With Impella RP Flex

Catheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Right ventricular (RV) failure after left ventricular assist device (LVAD) implantation is a serious complication which may necessitate temporary mechanical support in refractory cases. Here we describe a 63‐year‐old man with end‐stage ischemic cardiomyopathy and severe combined pre‐ and post‐capillary pulmonary hypertension who developed ...
Sara S. Inglis, Serena Rahme, Andrew N. Rosenbaum, Atta Behfar   +3 more
wiley   +1 more source

A Worldwide Perspective of Atypical Pathogens in Community-Acquired Pneumonia

, 2007
Rationale: Controversy still exists in the international literature regarding the need to use antimicrobials covering atypical pathogens when initially treating hospitalized patients with community-acquired pneumonia (CAP).
T. J. Marrie, P. Peyrani, J. Rello, P. Rossi, F. W. Arnold, J. A. Ramirez, L. Marzoratti, A. S. Lajoie, F.B.A. Blasi, P. Fernandez, Community Acquired Pneumonia Organitazion Investigators, C. M. Luna, R. Menendez, T. M. File, J. T. Summersgill   +14 more
core   +1 more source

Enhancing Evidence Generation by Linking Randomized Clinical Trials to Real‐World Data: The INVESTED‐Medicare Linkage Study

Clinical Pharmacology &Therapeutics, EarlyView.
Real‐world evidence (RWE) derived from real‐world data (RWD) can complement randomized controlled trials (RCTs), yet the validity of RWD relative to RCT data remains insufficiently characterized. We obtained post hoc consent and linked individual participant data from the US‐based INVESTED trial (2016–2019) with Medicare fee‐for‐service claims (2012 ...
Hanseul Cho, HoJin Shin, Mehdi Najafzadeh, Brian Claggett, Janinne Ortega‐Montiel, Jun Liu, Julie M. Paik, Narlina F. Lalani, Marie C. Bradley, John Concato, Scott D. Solomon, Orly Vardeny, Elisabetta Patorno   +12 more
wiley   +1 more source

Long‐Acting Therapeutics in Pediatric Health: Bridging Innovation and Access

Clinical Pharmacology &Therapeutics, EarlyView.
Children have distinct therapeutic needs arising from age‐dependent physiology, disease epidemiology, formulation requirements, dosing considerations, and safety vulnerabilities. Despite substantial reductions in childhood mortality over the past three decades, nearly 5 million children under five died in 2023, with infectious diseases continuing to ...
Prajith Venkatasubramanian, Moherndran Archary, Daniel B. Hawcutt, Rachel Daley, Edmund Capparelli, Adeniyi Olagunju   +5 more
wiley   +1 more source

Continual improvement in ventilator acquired pneumonia bundle compliance: A retrospective case matched review

, 2012
Objectives: This study aimed to describe the population of people who acquired ventilator acquired pneumonia and determine the feasibility of a larger scale study to assess the degree to which bundle compliance reduces or even eliminates, the risk of ...
Beattie, Michelle, Maher, Shaun, Grant, Janice, Shepherd, Ashley   +3 more
core   +1 more source

Progress report on new epilepsy treatments: A summary of the Eighteenth Eilat Conference on New Antiepileptic Drugs and Devices (EILAT XVIII). II. Treatments in more advanced clinical development

Epilepsia, EarlyView.
Abstract This article summarizes data for 13 investigational treatments for which at least preliminary seizure outcome data in patients with epilepsy were reported at the Eighteenth Eilat Conference on New Antiepileptic Drugs and Devices held in Madrid, Spain, on May 3–6, 2026.
Meir Bialer, Cecilie Johannessen Landmark, Matthias J. Koepp, Emilio Perucca, Piero Perucca, Torbjörn Tomson, H. Steve White, Elaine Wirrell   +7 more
wiley   +1 more source

The pneumonia severity index predicts time to clinical stability in patients with community-acquired pneumonia

, 2006
SETTING: A total of 33 hospitals in 13 countries in North America, Europe, Africa, Asia and Latin America. OBJECTIVE: To investigate the relationship between the pneumonia severity index (PSI) and the time to clinical stability from intravenous to oral ...
A. LaJoie, J. Roig, J. Ramirez, J. Rello, P. Rossi, Community Acquired Pneumonia Organization, E. Rodriguez, P. Fernandez, T. Marrie, K. Weiss, G. Levy, F. Blasi, C. Luna, C. Feldman, J. Porras, F. Arnold, F. Arteta   +16 more
core   +2 more sources

Pneumonia in Intensive Care Unit

Indian Journal of Anaesthesia, 2008
No large data based, or randomized controlled studies are available in reference to pneumonia in ICU especially in adult population, in India. Moreover the types of ICU infrastructure, sterilization& disinfection protocols, empirical antibiotics and ...
Vinay Joshi, Gurjar Mohan
doaj  

Problems of choosing antimicrobial therapy in young children with community-acquired pneumonia

Медицинский вестник Юга России
Objective: to analyze the prescribed antimicrobial therapy in young children with non-severe community-acquired pneumonia. Materials and methods: a sample of 219 young children with community-acquired pneumonia admitted to the pediatric department of the
Z. A. Shangareeva, R. M. Faizullina, A. V. Sannikova, A. F. Mananova, O. L. Berezina, O. V. Islamgulova, L. V. Pererva, A. V. Larina   +7 more
doaj   +1 more source